Significant Ownership of Paradigm Biocapital Advisors LP

Signature - Title
/s/ David K. Kim - David K. Kim / Authorized Signatory
Location
New York, NY
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Paradigm Biocapital Advisors LP.

Notify me when Paradigm Biocapital Advisors LP files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Paradigm Biocapital Advisors LP

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
OLMA Olema Pharmaceuticals, Inc. Common Stock, $0.0001 par value per share 10% $37,443,949 7,429,355 Paradigm BioCapital Advisors LP 31 Dec 2024
ACLX Arcellx, Inc. Common Stock, $0.001 par value per share 9.9% $379,330,540 5,724,016 Paradigm BioCapital Advisors LP 31 Dec 2025
URGN UroGen Pharma Ltd. Ordinary Shares, par value NIS 0.01 per share 9% $84,110,876 +$37,586,159 4,216,084 +81% Paradigm BioCapital Advisors LP 30 Sep 2025
LXEO Lexeo Therapeutics, Inc. Common Stock, $0.0001 par value per share 6.5% $35,390,561 +$8,107,609 4,763,198 +30% Paradigm BioCapital Advisors LP 31 Dec 2025
EWTX Edgewise Therapeutics, Inc. Common Stock, $0.0001 par value per share 6.2% $161,371,651 +$44,462,272 6,541,210 +38% Paradigm BioCapital Advisors LP 31 Dec 2025
ERAS Erasca, Inc. Common Stock, $0.0001 par value per share 5.3% $56,391,833 15,159,095 Paradigm BioCapital Advisors LP 07 Jan 2026
EYPT EyePoint, Inc. Common Stock, $0.001 par value per share 5.1% $64,770,432 4,192,261 Paradigm BioCapital Advisors LP 17 Feb 2026
AGIO Agios Pharmaceuticals, Inc. Common Stock, $0.001 par value per share 4.9% $115,344,498 -$6,198,499 2,873,555 -5.1% Paradigm BioCapital Advisors LP 30 Sep 2025
JANX Janux Therapeutics, Inc. Common Stock, $0.001 par value per share 4.9% $73,444,489 -$14,982,559 2,920,258 -17% Paradigm BioCapital Advisors LP 30 Jun 2025
VOR VOR Biopharma Inc. Common Stock, $0.0001 par value per share 4.5% $23,730,000 1,750,000 0% Paradigm BioCapital Advisors LP 31 Dec 2025
LENZ LENZ Therapeutics, Inc. Common Stock, $0.00001 par value per share 3.8% $50,001,813 -$16,133,961 1,073,461 -24% Paradigm BioCapital Advisors LP 30 Sep 2025
IRON Disc Medicine, Inc. Common Stock, $0.0001 par value per share 3.5% $57,097,283 1,210,971 Paradigm BioCapital Advisors LP 31 Mar 2025
CDTX Cidara Therapeutics, Inc. Common Stock, $0.0001 par value per share 3.3% $92,041,065 -$16,034,916 961,164 -15% Paradigm BioCapital Advisors LP 30 Sep 2025
COGT Cogent Biosciences, Inc. Common Stock, $0.001 par value per share 2.3% $45,325,875 -$103,335,292 3,156,398 -70% Paradigm BioCapital Advisors LP 30 Sep 2025
PLRX Pliant Therapeutics, Inc. Common Stock, $0.0001 par value per share 0% $0 0 Paradigm BioCapital Advisors LP 31 Mar 2025
KURA Kura Oncology, Inc. Common Stock, $0.0001 par value per share 0% $0 0 Paradigm BioCapital Advisors LP 31 Dec 2024
YMAB Y-mAbs Therapeutics, Inc. Common Stock, $0.0001 par value per share 0% $0 0 Paradigm BioCapital Advisors LP 30 Sep 2025
MRUS Merus N.V. Common Shares, (euro)0.09 nominal value per share 0% $0 -$420,639,300 0 -100% Paradigm BioCapital Advisors LP 31 Dec 2025

Schedules 13D/G Reported by Paradigm Biocapital Advisors LP:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.